Emerging Leaders: Roche And Viking Therapeutics In The Obesity Treatment Race [Seeking Alpha]
Roche Holding AG (OTCMKTS: RHHBY) was upgraded by analysts at Deutsche Bank Aktiengesellschaft from a "sell" rating to a "hold" rating.
Canopy and Flatiron Health Announce Partnership to Streamline Continuous Care Management for OncoEMR® Customers [Yahoo! Finance]
[Ad hoc announcement pursuant to Art. 53 LR] Roche reports positive Phase I results for its dual GLP-1/GIP receptor agonist CT-388 in people with obesity [Yahoo! Finance]
Genentech Reports Positive Phase Ib Results for Its Dual GLP-1/GIP Receptor Agonist CT-388 in People With Obesity